The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients.
Idorsia’s future success entirely depends on our people.
Idorsia's development compounds target a number of different diseases.
|Annual General Meeting of Shareholders 2019||May 3, 2019|
|Half-Year 2019 Financial Results reporting*||July 23, 2019|
|Nine-months 2019 Financial Results reporting*||October 22, 2019|
|Full-Year 2019 Financial Results reporting*||February 6, 2020|
*We will be in a silent period for 10 days ahead of the financial reporting.